Showing results (1841-1850 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|November 7, 2022
Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligandsHaeyoun Choi, Yunkyung Lee, Soon A Park, et al.
Oncoimmunology|October 10, 2022
A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx)Linlin Guo, Jay Overholser, Heather Darby, et al.
Oncoimmunology|October 10, 2015
High-throughput monitoring of human tumor-specific T-cell responses with large peptide poolsMathieu F Chevalier, Sara Bobisse, Carla Costa-Nunes, et al.
Oncoimmunology|October 10, 2015
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironmentValentino Le Noci, Monica Tortoreto, Alessandro Gulino, et al.
Oncoimmunology|October 10, 2015
Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansionLi-Yuan Chang, Yung-Chang Lin, Jy-Ming Chiang, et al.
Oncoimmunology|October 10, 2015
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanismsSimona Porcellini, Claudia Asperti, Barbara Valentinis, et al.
Oncoimmunology|October 10, 2015
IL-1βR-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteriaSabine Kuhn, Jianping Yang, Evelyn J Hyde, et al.
Oncoimmunology|October 10, 2015
Therapeutic potential of interleukin-27 against cancers in preclinical mouse modelsIzuru Mizoguchi, Yukino Chiba, Jun-Ichi Furusawa, et al.
Oncoimmunology|October 10, 2015
Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantationColin de Haar, Maud Plantinga, Nina Jg Blokland, et al.
Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.
Pageof 380